Key Takeaways

  • MGAM’s CFO Richard Armitage exercised 4,285 Sharesave Options under the 2022 grant at £2.10 per share.
  • The transaction was made outside of a trading venue, reflecting the nature of a Sharesave scheme exercise.
  • The disclosure was made under Article 19 of the UK Market Abuse Regulation, the standard PDMR framework.
  • The ordinary shares involved are 25p ordinary shares with ISIN GB0006027295 and LEI I4K14LL95N2PHDL7EG85.
  • Sharesave option exercises are common, employee-aligned events and are generally treated as routine by the market.

Introduction

Morgan Advanced Materials plc (LSE:MGAM), the UK-listed advanced materials and engineered solutions group that trades on the London Stock Exchange under the ticker MGAM, released a Director/PDMR Shareholding notification on 26 May 2026. The disclosure was published via the LSE’s Regulatory News Service at 17:21:00 under RNS Number 7531F.

The filing relates to the exercise of Sharesave options by the company’s Chief Financial Officer, Richard Armitage. Although small in scale, the disclosure forms part of the regulatory mosaic that allows investors to monitor insider transactions involving senior management.

This article explains the substance of the announcement, the mechanics of a Sharesave scheme exercise, and how investors may interpret such disclosures within the broader context of Morgan Advanced Materials’ Business and its Capital Structure.

What the Company Announced

According to the LSE announcement, Morgan Advanced Materials plc disclosed a notification of transactions of Directors and Persons Discharging Managerial Responsibilities (PDMRs). The filing names Richard Armitage, the Group’s Chief Financial Officer, as the PDMR concerned, and identifies the issuer as Morgan Advanced Materials plc with LEI I4K14LL95N2PHDL7EG85.

The financial instrument involved is ordinary shares of 25 pence each with ISIN GB0006027295. The nature of the transaction is described as the exercise of 4,285 Sharesave options granted on 23 September 2022, at an option price of £2.10 per share.

The notice indicates an initial notification rather than an amendment to an earlier filing, and is given in fulfilment of the obligation under Article 19 of the UK Market Abuse Regulation.

Key Details from the LSE Announcement

The 26 May 2026 RNS sets out the key data points investors typically focus on when reviewing a Director/PDMR shareholding disclosure.

PDMR Identity and Role

The PDMR named in the disclosure is Richard Armitage, in his capacity as PDMR – CFO. The filing identifies the issuer as Morgan Advanced Materials plc and references the company’s Legal entity Identifier.

Nature and Volume of the Transaction

The transaction is described as the exercise of 4,285 Sharesave options granted on 23 September 2022 at an option price of £2.10 per share. The aggregated volume box is recorded as not applicable, reflecting the simple structure of the disclosure as a single transaction record.

Date and Venue

The date of the transaction is 26 May 2026. The place of the transaction is recorded as outside of a trading venue, which is typical for the exercise of employee share options that are settled directly via the company or a scheme administrator rather than on the order book of an exchange.

Why the Announcement Matters

Director and PDMR shareholding announcements are a key element of the UK’s market transparency framework. Article 19 of the UK Market Abuse Regulation requires senior managers of listed companies, and persons closely associated with them, to publicly disclose transactions in the company’s securities.

Sharesave exercises typically reflect long-running employee share scheme participation. They tend to be regarded as more routine than open-market purchases or sales because they are linked to a pre-set option price and grant date. Nonetheless, they form part of the broader record of insider transaction activity that investors and analysts monitor.

For Morgan Advanced Materials, the 26 May 2026 filing provides a small but useful data point about how its long-term incentive and employee share plans are progressing through their natural lifecycle.

Company Background

Morgan Advanced Materials plc is a UK-listed engineered materials and solutions group with a global footprint. The company operates across applications including thermal management, energy-related ceramics, carbon and graphite products, and other advanced materials used in demanding industrial environments.

The Group trades on the London Stock Exchange under the ticker MGAM. Its ordinary shares of 25 pence each are identified by ISIN GB0006027295, with the company’s Legal Entity Identifier referenced as I4K14LL95N2PHDL7EG85 in the 26 May 2026 RNS.

Morgan Advanced Materials operates long-standing employee share schemes, of which the Sharesave plan referenced in the latest filing is a common UK structure. Such schemes are intended to encourage broad-based employee Equity ownership over multi-year contribution periods.

Market and Sector Context

The UK advanced materials and industrial engineering sector tends to attract investors with a focus on long-cycle Capital Expenditure and specialist technology applications. Companies in this segment often have significant exposure to international industrial end markets, and their financial performance reflects movements in global Manufacturing activity.

Within this broader context, PDMR shareholding disclosures linked to employee share schemes are an expected feature of regulatory news. They become more interpretive when combined with other data points, such as open-market purchases or sales, that may signal a stronger view by executives on the company’s share price.

The 26 May 2026 MGAM filing fits comfortably within the routine end of the PDMR spectrum, given that it relates to the exercise of historically granted Sharesave options.

What It May Mean for Shareholders or Investors

For Morgan Advanced Materials shareholders, the disclosure of the Sharesave option exercise by CFO Richard Armitage is procedural rather than directional. It confirms that long-standing share scheme arrangements are being executed transparently and within the framework of the UK Market Abuse Regulation.

Retail investors may find the announcement most useful as a reminder of how UK Sharesave schemes work. Employees contribute a fixed amount each month over a typical three- or five-year period, and then have the right, but not the obligation, to exercise options to buy shares at a pre-agreed price set at the start of the scheme.

Professional investors will typically integrate the filing into their PDMR monitoring tools alongside other disclosures from MGAM and comparable companies, looking at the pattern of activity rather than any single event.

Risks and Points to Watch

While the 26 May 2026 disclosure is routine in nature, there are several points that investors may wish to keep in mind when interpreting future PDMR filings from Morgan Advanced Materials.

First, the size and timing of Sharesave option exercises depend on when individual employees choose to act, and on the Maturity dates of underlying option grants. Volumes may vary substantially without indicating any change in management sentiment.

Second, any subsequent sale of the underlying shares (for example, to fund the exercise price or related tax liabilities) would typically be the subject of a further PDMR disclosure if applicable. The current filing relates solely to the exercise of options at the £2.10 Strike Price.

Third, broader sector trends, including industrial Demand cycles and currency movements, can influence the perceived significance of PDMR activity at any one time.

What Happens Next

Following the 26 May 2026 RNS, Richard Armitage’s exercise of 4,285 Sharesave options at £2.10 per share is now on the public record. Any subsequent dealings by Mr Armitage in Morgan Advanced Materials securities will require fresh Article 19 disclosures.

Investors will be able to monitor future PDMR activity through the company’s regulatory news feed on the London Stock Exchange, alongside other corporate updates such as trading statements and results announcements.

Investor Glossary and Article 19 in Context

Article 19 of the UK Market Abuse Regulation is the cornerstone of the PDMR transparency regime in the United Kingdom. It requires persons discharging managerial responsibilities, and persons closely associated with them, to notify the issuer and the Financial Conduct Authority of all transactions conducted on their own account in the issuer’s shares, Debt instruments, Derivatives or other financial instruments linked to them.

A PDMR is broadly defined and typically includes the chief executive officer, chief financial officer, other senior executives with material decision-making authority, and members of the Board of Directors. The definition can extend further if other individuals have regular access to inside information and the power to take managerial decisions affecting the future developments and business prospects of the issuer.

Persons closely associated with a PDMR can include their spouse or partner, dependent children, certain relatives and legal entities controlled by the PDMR. Transactions conducted by those persons in the issuer’s securities are also captured by the disclosure regime, which helps to ensure that the transparency framework cannot be circumvented through indirect dealings.

A Sharesave scheme, also known as a Save-As-You-Earn (SAYE) plan, allows participating employees to save a fixed monthly amount from their salary over a typical three- or five-year period. At the end of that period, employees can choose to use the accumulated savings to exercise options to buy shares at the strike price set at the start of the scheme, or to take their savings back as cash. Sharesave schemes are a long-standing feature of UK corporate life and are intended to support broad-based employee ownership.

For Morgan Advanced Materials, the 26 May 2026 PDMR disclosure is a textbook example of the interaction between the Sharesave scheme structure and the Article 19 transparency framework. The CFO has exercised options under the September 2022 grant at the original £2.10 strike price, and the resulting transaction has been disclosed promptly and transparently in line with regulatory requirements.

Conclusion

The 26 May 2026 Director/PDMR Shareholding notification from Morgan Advanced Materials plc is a textbook example of an Article 19 disclosure linked to a long-standing employee share scheme. CFO Richard Armitage’s exercise of 4,285 Sharesave options at £2.10, originally granted in September 2022, is a routine but important event in the lifecycle of the company’s employee equity arrangements.

For investors, the filing is best understood as part of the broader regulatory transparency framework rather than as a directional signal. The LSE’s Regulatory News Service will continue to be the primary channel for any further PDMR disclosures and other corporate updates from the company.